Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent CD-JEV and MMR Vaccine in Infants
NCT02880865Phase 4Completed
- Sponsor
- PATH
- Start
- Oct 2016
- Primary completion
- May 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of japanese encephalitis vaccine sa14-14-2 in Japanese encephalitis (JE), sponsored by PATH. Started Oct 2016; status: completed.
02
Drugs
japanese encephalitis vaccine sa14-14-2
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT02880865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880865.